Evidence map›Paper›PMID 42547572›Full record

ArticleNature immunology2026

Tissue-resident immune cells drive genetic risk in autoimmune and lung diseases.

Benjamin J Schmiedel, Cristian Gonzalez-Colin, Vicente Fajardo-Rosas, Job Rocha, Hayley Simon, Johannes Ottensmeier, Ignacio E Ramírez-Bernabé, April Cano, Angel De la Cruz Castillo, Elizabeth Márquez-Gómez and 14 more

Abstract read
In one paragraph

Article in Nature immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Where risk resides.Nature immunology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Benjamin J SchmiedelLa Jolla Institute for Immunology, La Jolla, CA, USA. bschmiedel@lji.org.ORCID http://orcid.org/0000-0002-9103-9378
Cristian Gonzalez-ColinLa Jolla Institute for Immunology, La Jolla, CA, USA.
Vicente Fajardo-RosasLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-1578-7438
Job RochaLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-1292-2307
Hayley SimonLa Jolla Institute for Immunology, La Jolla, CA, USA.
Johannes OttensmeierLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID http://orcid.org/0009-0003-7081-7964
Ignacio E Ramírez-BernabéLa Jolla Institute for Immunology, La Jolla, CA, USA.
April CanoLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID http://orcid.org/0009-0006-4324-0727
Angel De la Cruz CastilloLa Jolla Institute for Immunology, La Jolla, CA, USA.
Elizabeth Márquez-GómezLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID http://orcid.org/0009-0009-5669-9432
Brendan HaLa Jolla Institute for Immunology, La Jolla, CA, USA.
Jason A GreenbaumLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-1381-0390
Lindsey ChudleyDepartment of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.ORCID http://orcid.org/0000-0002-5202-7104
Judith CaveUniversity Hospital Southampton NHS Foundation Trust, Southampton, UK.
Aiman AlzetaniUniversity Hospital Southampton NHS Foundation Trust, Southampton, UK.
Edwin WooUniversity Hospital Southampton NHS Foundation Trust, Southampton, UK.
Michael ShackclothLiverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK.ORCID http://orcid.org/0000-0002-6494-9907
Serena J CheeDepartment of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
Vivek ChandraLa Jolla Institute for Immunology, La Jolla, CA, USA.
Mitchell KronenbergLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID http://orcid.org/0000-0001-6318-6445
Bjoern PetersLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-8457-6693
Christian H OttensmeierLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-3619-1657
Anusha-Preethi GanesanLa Jolla Institute for Immunology, La Jolla, CA, USA.ORCID http://orcid.org/0000-0003-3775-9996
Pandurangan VijayanandLa Jolla Institute for Immunology, La Jolla, CA, USA. vijay@lji.org.ORCID http://orcid.org/0000-0001-7067-9723

Funding

Research Resources: Epigenomic and Transcriptomic Profiles of Human Immune CellsR24AI108564 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI MITCHELL KRONENBERG, Bjoern Peters · 2014 to 2026
$12.1M
Mechanisms underlying tumor-infiltrating tissue resident memory T cell generation and maintenanceK08CA230164 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GANESAN, ANUSHA PREETHI · 2019 to 2023
$1.4M
NovaSeq5000 High Throughput SequencerS10OD025052 · OD · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SEUMOIS, GREGORY · 2018 to 2018
$832k
Illumina NovaSeq 6000 Sequencing SystemS10OD026929 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEPSEN, KRISTEN LYNN · 2019 to 2019
$600k
FACSAria II Cell SorterS10RR027366 · NCRR · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2011 to 2011
$514k
Experimental identification of functional GWAS variants linked to COVID-19 severity in immune cellsR21AI173927 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SCHMIEDEL, BENJAMIN JOACHIM · 2023 to 2024
$503k
NCI NIH HHS K08 CA230164NCRR NIH HHS S10 RR027366NIAID NIH HHS R21 AI173927NIAID NIH HHS R24 AI108564NIH HHS S10 OD025052NIH HHS S10 OD026929U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R24 AI108564
6 · The paper itself

Abstract

Common genetic variants are associated with risk of lung and autoimmune diseases. However, we have a limited understanding of the pathological effects of these disease variants, specifically in tissue-resident immune cells at the frontier of infection and disease in the lung. To address this, we performed single-cell expression quantitative trait locus (eQTL) analysis across 29 distinct immune cell subsets isolated from lung tissue. Colocalization analysis of lung immune cell eQTLs with genome-wide association study (GWAS) signals from lung diseases, and infectious and autoimmune diseases, implicate disease-associated variants and their target genes functioning in a single or restricted group of cell types. Several genes, including ZFP57, showed significant colocalization between lung immune cell eQTLs and GWAS signals from multiple systemic and organ-restricted autoimmune diseases, highlighting shared genetic mechanisms underlying the risk of disease. Overall, our study shows that disease-associated variants from a wide range of autoimmune diseases impact gene expression in tissue-resident immune cell types ( https://lung.dice-database.org ).

Indexed as

Autoimmune DiseasesGenetic Predisposition to DiseaseLung DiseasesAnimalsGenome-Wide Association StudyHumansLungPolymorphism, Single NucleotideQuantitative Trait Loci

Identifiers

PMID42547572
PMCPMC13506332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.